studi
infect
mice
engraft
human
peripher
blood
leukocyt
hupblnoj
measl
viru
edmonston
b
strain
mvedm
express
hepat
c
viru
hcv
envelop
protein
evalu
immunogen
vaccin
candid
although
human
leukocyt
could
isol
spleen
mockinfect
mice
experi
proport
engraft
human
leukocyt
mice
infect
mv
pfu
pfu
decreas
viral
infect
splenocyt
confirm
develop
cytopath
effect
cpe
cocultur
splenocyt
cell
verifi
use
rtpcr
final
human
antibodi
mv
frequent
observ
antibodi
serum
mice
infect
low
dose
viru
mv
pfu
pfu
result
show
possibl
hupblnoj
mice
evalu
immunogen
viral
protein
hepat
c
viru
hcv
member
flavivirida
famili
caus
agent
chronic
hepat
hepatocellular
carcinoma
hcc
million
peopl
infect
hcv
worldwid
despit
prevent
effort
advanc
treatment
strategi
includ
combin
pegyl
alpha
interferron
ribavirin
therapi
clinic
efficaci
treatment
limit
altern
novel
antivir
agent
shown
elicit
effect
respons
chronic
infect
patient
inhibitor
viral
proteas
helicas
polymeras
current
develop
expens
therefor
develop
effect
vaccin
either
induc
product
hightit
longlast
crossreact
neutralis
antibodi
induc
cellular
immun
respons
import
immunolog
approach
control
hcv
infect
proven
ineffect
part
hcv
adapt
escap
host
immun
system
furthermor
high
percentag
immunocompet
individu
infect
hcv
despit
abil
mount
activ
immun
respons
prevent
hcv
vaccin
requir
protect
unexpos
individu
hcv
infect
vaccin
like
need
target
viral
envelop
glycoprotein
must
also
bival
safe
provid
longlast
protect
immun
address
challeng
evalu
immunogen
liveattenu
recombin
vector
deriv
pediatr
measl
viru
mv
express
hcv
antigen
mv
vaccin
wellknown
liveattenu
vaccin
proven
one
safest
stabl
effect
human
vaccin
vaccin
produc
larg
scale
mani
countri
use
low
cost
extend
program
immunis
vaccin
shown
induc
lifelong
immun
singl
dose
boost
effect
effort
develop
vaccin
use
recombin
mv
express
differ
protein
deriv
dengu
viru
human
immunodefici
viru
hiv
human
papilloma
viru
hpv
sever
acut
respiratori
syndrom
sar
west
nile
viru
wnv
describ
construct
recombin
mv
express
envelop
glycoprotein
hcv
demonstr
viru
could
infect
cell
express
hcv
hcv
research
long
hamper
lack
anim
model
reproduc
hcv
infect
human
model
sever
combin
immunodefici
scid
mice
transplant
human
peripher
blood
leukocyt
pbl
wellestablish
system
studi
human
immun
hupblscid
mous
develop
human
lymphoid
cell
lineag
repopul
anim
lymphoid
organ
group
previous
gener
nonobes
diabet
nod
scidjanu
kinas
knockout
noj
mous
model
establish
human
hemolymphoid
system
mous
studi
infect
human
pbltransplant
noj
mice
mv
characteris
humor
immun
respons
elicit
transplant
human
cell
order
evalu
vaccin
candid
cell
marmoset
b
cell
line
use
viral
titrat
rescu
maintain
rpmi
medium
supplement
heatinactiv
foetal
calf
serum
fc
cdna
encod
hcv
obtain
plasmid
use
replicationcompet
mvbase
vector
pmv
edmonston
b
strain
mv
cdna
clone
fse
site
pmv
result
clone
use
rescu
infecti
recombin
mv
express
hcv
envelop
glycoprotein
report
previous
mice
reconstitut
describ
previous
null
strain
establish
backcross
null
nod
cgprkdc
scid
strain
ten
gener
anim
experi
perform
accord
guidelin
institut
anim
committe
ethic
committe
kumamoto
univers
peripher
blood
leukocyt
isol
blood
donor
use
ficollhypaqu
densiti
gradient
centrifug
total
cell
transplant
spleen
irradi
gy
mice
inject
pfu
mv
pfu
intraperiton
mv
infect
respect
neg
control
group
mice
inject
rpmi
mice
monitor
week
euthanis
spleen
peripher
blood
collect
analysi
isol
splenocyt
stain
antimous
bd
pharmingen
detect
murin
leukocyt
either
apcor
pacif
blueconjug
antihuman
dako
detect
human
leukocyt
data
analys
use
flowjo
tree
star
viral
infect
human
leukocyt
confirm
use
cocultur
cell
follow
rtpcr
suspens
isol
splenocyt
cocultur
cell
format
cytopath
effect
cpe
monitor
week
addit
rna
isol
supernat
cocultur
use
isogenl
nippon
gene
accord
manufactur
instruct
mv
rna
detect
use
revers
transcriptpcr
rtpcr
sens
primer
antisens
primer
hcv
amplifi
use
antimv
antibodi
titer
determin
use
elisa
assay
plate
coat
gml
solut
mvinfect
lysat
recombin
baculovirusinfect
lysat
antigen
respect
plate
consecut
incub
antimvnp
antibodi
millipor
usa
normal
mous
serum
nm
use
posit
control
neg
control
respect
total
protein
extract
baculovirusinfect
lysat
separ
sdspage
primari
antibodi
use
western
blot
follow
sera
mice
monoclon
antibodi
peroxidaseconjug
secondari
antibodi
ad
incub
mixtur
h
room
temperatur
hcv
gene
correspond
envelop
protein
subclon
n
p
gene
mv
vector
fig
hcv
gene
includ
put
signal
peptid
sequenc
n
terminu
transmembran
domain
c
terminu
plasmid
vector
introduc
support
plasmid
cell
rescu
recombin
virus
express
protein
examin
western
blot
fig
immunofluoresc
fig
hupblnoj
mous
infect
observ
day
fig
infect
mv
confirm
first
cocultur
human
leukocyt
isol
spleen
infect
mice
cell
verifi
presenc
viru
rtpcr
mv
pfu
pfu
infect
hupblnoj
mice
cpe
observ
cocultur
splenocyt
tabl
fig
result
cocultur
assay
agreement
result
obtain
rtpcr
posit
band
observ
mice
infect
pfu
mv
pfu
fig
result
demonstr
rescu
mv
abl
infect
transplant
human
pbl
also
examin
splenocyt
infect
mice
simultan
use
flow
cytometri
determin
proport
human
cell
spleen
fig
tabl
mvinfect
hupblnoj
mice
popul
human
leukocyt
observ
mice
infect
pfu
wherea
human
leukocyt
observ
mice
infect
pfu
contrast
mice
popul
human
leukocyt
detect
mice
inocul
pfu
ratio
human
leukocyt
settlement
group
mice
invers
correl
result
rtpcr
cocultur
assay
tabl
examin
immun
respons
mv
transplant
human
pbl
measur
human
mvor
hcvspecif
antibodi
use
elisa
mvinfect
cell
lysat
fig
recombin
hcv
protein
fig
signific
amount
human
antibodi
mv
antigen
detect
sera
mice
infect
mv
pfu
pfu
fig
b
howev
one
mous
infect
pfu
gener
human
antibodi
hcv
fig
antibodi
respons
mous
confirm
western
blot
analysi
fig
develop
vaccin
hcv
reli
sever
tool
includ
recombin
protein
peptid
deriv
hcv
antigen
hcv
protein
play
essenti
role
entri
hcv
host
cell
therefor
protein
repres
ideal
target
neutralis
antibodi
block
viral
entri
sever
studi
use
measl
viru
vector
express
viral
protein
studi
examin
infect
rescu
edmonston
b
strain
mv
recombin
construct
use
revers
genet
demonstr
virus
infect
hupblnoj
mice
first
report
demonstr
rescu
viru
includ
recombin
viru
infect
hupblnoj
mice
furthermor
adequ
viral
titer
could
control
gener
antibodi
mice
base
flow
cytometri
data
human
leukocyt
disappear
follow
infect
high
viru
titer
pfu
human
antibodi
detect
mice
data
shown
contrast
popul
human
leukocyt
detect
mice
inocul
lower
dose
viru
pfu
addit
could
detect
human
antibodi
serum
mice
infect
low
dose
viru
suggest
viral
titer
rang
suitabl
induct
antibodi
respons
target
rmv
hupblnoj
mous
system
rang
viru
concentr
adequ
antibodi
product
result
antibodi
respons
might
suppress
viral
growth
pfu
mv
hupblnoj
mice
humanis
mous
promis
model
studi
transmiss
live
attenu
edmonston
b
strain
measl
viru
sever
report
detail
infect
experiment
transgen
mice
express
human
strain
measl
viru
howev
unlik
anim
model
popul
human
cell
target
viru
studi
furthermor
use
hupblnoj
mice
allow
one
monitor
immun
respons
gener
human
leukocyt
immunogen
base
result
hupblnoj
mice
use
tool
studi
immun
respons
earli
mv
infect
sinc
anim
model
hcv
infect
monitor
immun
respons
human
leukocyt
permit
accur
evalu
potenti
vaccin
candid
detect
signific
amount
mvspecif
antibodi
mice
n
howev
one
mous
produc
antibodi
mice
produc
antibodi
result
could
explain
hypothesi
immunogen
especi
protein
might
lower
immunogen
mv
protein
observ
consist
previou
studi
develop
hupblnoj
mous
model
system
allow
us
characteris
immedi
immun
respons
also
longterm
evolut
human
immun
respons
measl
viru
recombin
measl
virus
system
make
possibl
evalu
immunogen
potenti
vaccin
target
use
human
pbl
indispens
develop
effect
vaccin
hcv
